Welcome to our dedicated page for MDB Capital Holdings LLC-A SEC filings (Ticker: MDBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MDB Capital Holdings, LLC (NASDAQ: MDBH) files regulatory reports with the U.S. Securities and Exchange Commission as a Delaware limited liability company in the investment banking and securities dealing sector. These SEC filings provide formal information on the company’s governance, capital structure, shareholder voting, and financial reporting, and are a key resource for understanding MDB’s public venture platform and its broker-dealer and intellectual property service activities.
Among the important documents for MDBH are annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited and interim financial statements, segment information for the broker dealer & intellectual property service and technology development segments, and discussions of risk factors and business strategy. Investors also review current reports on Form 8-K for material events, such as significant transactions, strategic initiatives, or changes affecting shareholders.
Proxy statements on Schedule 14A, such as MDB Capital Holdings’ definitive proxy statement for its annual meeting of shareholders, detail matters submitted to a shareholder vote. These include the election of directors, ratification of the independent registered public accounting firm, and information on board structure, executive compensation, and security ownership. The proxy materials also explain voting procedures for holders of Class A and Class B shares and describe how quorums and vote counts are determined.
On this SEC filings page, users can access MDBH filings as they are made available through EDGAR. AI-powered tools can help summarize lengthy documents, highlight key sections on topics like governance, segment reporting, and shareholder rights, and make it easier to interpret complex proxy and annual report disclosures related to MDB Capital Holdings’ public venture and intellectual property-focused business model.
MDB Capital Holdings CFO James Jeremy William reported equity-based acquisitions of company stock. On February 9, 2026, he received 10,000 shares of Common Stock as a grant at $3.90 per share, increasing his direct holdings to 39,839 shares.
On April 20, 2026, he exercised 10,000 RSUs into 10,000 shares of Class A Common Stock at a conversion price of $0.00. Following this derivative exercise, his direct ownership rose to 50,000 shares. The filing shows only acquisitions, with no reported sales or tax-withholding dispositions.
MDB Capital Holdings, LLC director Torpey Daniel Thomas reported acquiring additional equity in the company. On April 20, 2026, he received 10,000 shares of Common Stock at a stated value of $3.90 per share as a grant or award, bringing his direct Common Stock holdings to 47,100 shares after the transaction. The same day, he also exercised 10,000 RSUs at a conversion price of $0.00 per unit into 10,000 underlying Class A shares, a derivative exercise that increased his equity exposure without any reported open-market buying or selling.
MDB Capital Holdings director Sean James Magennis increased his direct stake through compensation-related equity events. On April 20, 2026, he exercised 10,000 RSUs into Class A shares at an exercise price of $0.00 per share. Earlier, on February 9, 2026, he received a grant of 10,000 shares of common stock at a reference price of $3.90 per share. After these acquisitions, he directly owned 50,000 shares of MDB Capital Holdings common stock.
MDB Capital Holdings, LLC director Terry Jeb Barton Sr. filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows indirect ownership of 4,166 Class A Common Shares of MDB Capital Holdings, held through his spouse as of the reported date.
Terry Jeb Barton Sr. reported acquisition or exercise transactions in this Form 4 filing.
MDB Capital Holdings, LLC director Terry Jeb Barton Sr. received an award of 100,000 Employee Stock Options on February 1, 2026. The options are exercisable at $3.19 per share for 100,000 Class A shares and expire on February 1, 2031. Following this grant, he holds 100,000 derivative securities directly.
MDB Capital Holdings, LLC files its annual report outlining a public venture capital platform built around founding and financing early-stage technology companies. Through subsidiaries Public Ventures and PatentVest, MDB sources disruptive IP, structures partner companies, and raises capital from a long-term, community-oriented investor base.
The company highlights its Big Idea Pipeline, prior billion‑dollar partner outcomes, and a new longevity-focused partner, MDB Minnesota One, which licensed anti-senescence technology from Mayo Clinic. MDB operates as a Delaware LLC intended to be taxed as a partnership, with detailed risk factors on taxation, regulation, cybersecurity, and capital needs.
MDB Capital Holdings, LLC files its annual report outlining a public venture capital platform built around founding and financing early-stage technology companies. Through subsidiaries Public Ventures and PatentVest, MDB sources disruptive IP, structures partner companies, and raises capital from a long-term, community-oriented investor base.
The company highlights its Big Idea Pipeline, prior billion‑dollar partner outcomes, and a new longevity-focused partner, MDB Minnesota One, which licensed anti-senescence technology from Mayo Clinic. MDB operates as a Delaware LLC intended to be taxed as a partnership, with detailed risk factors on taxation, regulation, cybersecurity, and capital needs.
MDB Capital Holdings director Sean James Magennis reported acquiring additional equity in the company on February 9, 2026. He exercised 10,000 RSUs at an exercise price of $0.00, receiving the same number of Class A shares, and separately was granted or otherwise acquired 10,000 shares of common stock at $3.20 per share. Following these transactions, he directly holds 40,000 shares of common stock and 60,000 RSUs, all reported as direct ownership.
MDB Capital Holdings chief financial officer James Jeremy William reported new share-based transactions in MDBH. On February 9, 2026, he acquired 10,000 shares of Common Stock at $3.20 per share as a grant, bringing his directly held common shares to 29,839.
On the same date, he also exercised 10,000 restricted stock units (RSUs) at an exercise price of $0.00 per unit, with 60,000 RSUs reported as beneficially owned afterward. All reported holdings are listed as direct ownership.
MDB Capital Holdings director Daniel Torpey reported acquiring additional MDBH equity on February 9, 2026. He received a grant of 10,000 shares of common stock at $3.20 per share and exercised 10,000 RSUs into 10,000 Class A shares at an exercise price of $0.00. Following these transactions, he directly held 37,100 shares of common stock and 70,000 RSUs.
MDB Capital Holdings, LLC reported changes to its board of directors. Effective February 1, 2026, the board appointed Jeb Terry Sr. as an independent director and member of the audit committee, citing his long experience investing in microcap medical and biotechnology companies.
As director compensation, Mr. Terry will receive an annual cash payment of $50,000 and an option to acquire up to 100,000 Class A Shares under the 2022 Equity Incentive Plan. Of these, 20,000 Class A Shares vest on the first anniversary of the grant date, then 5,000 Class A Shares vest at the end of each three-month period thereafter, subject to continued service.
The company also disclosed that long-serving director Susanne Meline resigned from the board effective February 1, 2026 to pursue retirement, and the board expressed appreciation for her years of service.